Alloy is a biotech infrastructure company providing AI-enabled platforms and integrated services across multiple modalities, including antibodies, genetic medicines, and cell therapies. Building on its foundation in drug discovery, the company has expanded its capabilities across the full drug development lifecycle, including pharmacology, preclinical and clinical development support, as well as biologics manufacturing. Alloy enables a more efficient path from discovery to the clinic—reducing costs, shortening timelines, and increasing the probability of success.